The ACP/ACCP/ATS has issued updated guidelines for the management of patients with copd. The major recommendations include: treat only symptomatic patients regardless of stage, use spirometry to stage symptomatic patients, patients with an FEV1<60% should be treated with monotherapy (either long acting beta-agonist or long-acting anti-cholinergic) or dual therapy (combining long acting-beta agonist, steroid, or anti-cholinergic), and pulmonary rehab for all those with FEV1<50% or symptoms. The full guidelines are available from the ACP (link)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.